Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unspecified Adult Solid Tumor - Protocol Specific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00899808
What this trial is testing

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Rutgers, The State University of New Jersey
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00005078
What this trial is testing

Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 44
Early research (Phase 1)Ended earlyNCT00049088
What this trial is testing

Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01791088
What this trial is testing

Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
University of Chicago 56
Early research (Phase 1)Study completedNCT01358227
What this trial is testing

A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Proacta, Incorporated 26
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Not applicableStudy completedNCT00022165
What this trial is testing

Selenium in the Prevention of Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Surrey 501
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Early research (Phase 1)Study completedNCT00276536
What this trial is testing

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Breast CancerKidney CancerLymphoma+4 more
The Cleveland Clinic 35
Early research (Phase 1)Study completedNCT00003198
What this trial is testing

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01748721
What this trial is testing

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more
Morphotek 27
Early research (Phase 1)Study completedNCT00138177
What this trial is testing

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+4 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00091052
What this trial is testing

Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Sirius Medicine
Early research (Phase 1)WithdrawnNCT00072228
What this trial is testing

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Daiichi Pharmaceuticals
Early research (Phase 1)Study completedNCT00372736
What this trial is testing

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 27
Testing effectiveness (Phase 2)UnknownNCT00274859
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
GERCOR - Multidisciplinary Oncology Cooperative Group 45
Testing effectiveness (Phase 2)Ended earlyNCT01631279
What this trial is testing

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Proacta, Incorporated 33
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00182754
What this trial is testing

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 33
Next Page